1. Home
  2. MBINM vs BCTXL Comparison

MBINM vs BCTXL Comparison

Compare MBINM & BCTXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merchants Bancorp

MBINM

Merchants Bancorp

N/A

Current Price

$25.63

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo BriaCell Therapeutics Corp. Warrant expiring 2031

BCTXL

BriaCell Therapeutics Corp. Warrant expiring 2031

N/A

Current Price

$0.85

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MBINM
BCTXL
Founded
N/A
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2017
2025

Fundamental Metrics

Financial Performance
Metric
MBINM
BCTXL
Price
$25.63
$0.85
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.4K
3.6K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.73
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.00
$0.61
52 Week High
$25.96
$1.40

Technical Indicators

Market Signals
Indicator
MBINM
BCTXL
Relative Strength Index (RSI) 56.30 45.72
Support Level $25.30 $0.76
Resistance Level $25.77 $1.21
Average True Range (ATR) 0.12 0.09
MACD 0.00 -0.01
Stochastic Oscillator 87.10 47.80

Price Performance

Historical Comparison
MBINM
BCTXL

About MBINM Merchants Bancorp

Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.

About BCTXL BriaCell Therapeutics Corp. Warrant expiring 2031

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: